Volitionrx LTD balance sheet
At the end of fiscal 2025, Volitionrx LTD had total assets of $6.9m, total liabilities of $42.5m and shareholders' equity of −$34.2m. It held $1.1m in cash against $8.2m of debt: net debt of $7.1m.
Balance sheet
| Fiscal year | 2011Dec 2011 | 2012Dec 2012 | 2014Dec 2014 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0 | 0 | 2 | 17 | 19 | 21 | 11 | 21 | 3 | 1 | 3 |
| Receivables | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total current assets | 1 | 1 | 2 | 18 | 20 | 22 | 12 | 22 | 4 | 2 | 4 |
| Total assets | 2 | 2 | 3 | 21 | 26 | 27 | 18 | 28 | 9 | 7 | 8 |
| Accounts payable | — | — | — | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 4 |
| Deferred revenue (current) | — | — | — | — | — | 0 | 10 | 0 | 0 | 0 | 0 |
| Total current liabilities | 1 | 1 | 3 | 4 | 6 | 7 | 17 | 9 | 8 | 12 | 13 |
| Short-term debt | — | — | — | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Long-term debt | — | — | — | 2 | 3 | 2 | 3 | 4 | 4 | 6 | 6 |
| Total debt | 0 | 0 | 0 | 3 | 3 | 3 | 4 | 5 | 5 | 8 | 9 |
| Total liabilities | 1 | 1 | 3 | 7 | 10 | 10 | 21 | 37 | 36 | 42 | 42 |
| Shareholders' equity | 1 | 1 | 0 | 14 | 16 | 18 | −3 | −8 | −25 | −34 | −32 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | −1 | −1 | −1 | −1 | −1 |
| Net debt (negative = net cash) | −0 | −0 | −2 | −14 | −16 | −18 | −7 | −16 | 2 | 7 | 7 |
| Shares outstanding | 9m | 31m | 44m | 41m | 49m | 54m | 58m | 82m | 96m | — | 12m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total current assets | 7 | 4 | 3 | 3 | 1 | 2 | 5 | 4 |
| Total assets | 13 | 9 | 9 | 9 | 6 | 7 | 9 | 8 |
| Accounts payable | 2 | 3 | 3 | 2 | 3 | 3 | 4 | 4 |
| Deferred revenue (current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total current liabilities | 30 | 8 | 8 | 9 | 11 | 12 | 14 | 13 |
| Short-term debt | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Long-term debt | 4 | 4 | 6 | 6 | 6 | 6 | 6 | 6 |
| Total debt | 5 | 5 | 6 | 7 | 6 | 7 | 7 | 7 |
| Total liabilities | 35 | 36 | 38 | 42 | 42 | 42 | 42 | 42 |
| Shareholders' equity | −22 | −25 | −28 | −32 | −35 | −34 | −32 | −32 |
| Non-controlling interests and other (assets − liabilities − equity) | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 |
| Shares outstanding | 92m | 96m | 101m | 104m | 110m | 6m | 8m | 12m |
Compare with peers
- Femasys Inc balance sheet
- Icecure Medical Ltd. balance sheet
- Seastar Medical Holding Corp balance sheet
- Insight Molecular Diagnostics Inc. balance sheet
- Cerenome, Inc. balance sheet
Head to head: FEMY vs VNRXICCM vs VNRXICU vs VNRX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies